Auauniversity

AUA2021 Ramon Guiteras Lecture - Three Decades Of Bladder Cancer Treatment: Progress And Promise by AUAUniversity

Title: AUA2021 John K. Lattimer Lecture - Kidney Stones: Is Prevention Possible? Faculty: Glenn M. Preminger, MD Release: January 12

Testis Cancer – Apply the Guidelines to Clinical Practice by AUAUniversity

How to Safely and Properly Administer Immunotherapies Podcast (2021) CME Available: https://auau.auanet.org/node/33496 ACKNOWLEDGEMENTS This educational series is supported by independent educational grants from: Astellas AstraZeneca Lantheus Medical Imaging Merck Pfizer, Inc.

Management of Advanced Kidney Cancer: A Guide to Targeted Agents and Immunotherapies Podcast (2021) CME Available: auau.auanet.org/node/33488 ACKNOWLEDGEMENTS This educational series is supported by independent educational grants from: Astellas AstraZeneca Lantheus Medical Imaging Merck Pfizer, Inc.

Peer-Reviewed Guidance on How to Manage Immune-Related Adverse Events & Toxicities Podcast (2021) CME Available: auau.auanet.org/node/33492 This educational series is supported by independent educational grants from: Astellas AstraZeneca Lantheus Medical Imaging Merck Pfizer, Inc.

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline Update Podcast (2021) CME Available: auau.auanet.org/node/33467 This educational series is supported by independent educational grants from: Astellas AstraZeneca Lantheus Medical Imaging Merck Pfizer, Inc.

Support provided by independent educational grants from Astellas, Bayer HealthCare Pharmaceuticals Inc., Genentech, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC., Merck and Pfizer, Inc. CME Available: auau.auanet.org/node/31823 At the conclusion of this educational series, participants will be able to: 1. Discuss the impact of SDM on patients and on patient-clinician communication. 2. Identify at least one implementation strategy for using SDM in clinical practice. 3. Apply SDM techniques in a role-playing exercise with other colleagues. Incorporate culturally sensitive communications to ensure quality SDM and reduce biases. 4. Utilize the knowledge and experience they have gained through role-play into their routine practice-counseling patients.

Novel Imaging for High Risk Prostate Cancer Podcast (2021) CME Available: auau.auanet.org/node/33480 This educational series is supported by independent educational grants from: Astellas AstraZeneca Lantheus Medical Imaging Merck Pfizer, Inc.

Evolving Landscape of Androgen Deprivation Therapy in Advanced Prostate Cancer Podcast (2021) CME Available: auau.auanet.org/node/33472 This educational series is supported by independent educational grants from: Astellas AstraZeneca Lantheus Medical Imaging Merck Pfizer, Inc.

Identification and Management of Comorbid Conditions in the Patient with Advanced Prostate Cancer Podcast (2021) CME Available: https://auau.auanet.org/node/33476 This educational series is supported by independent educational grants from: Astellas AstraZeneca Lantheus Medical Imaging Merck Pfizer, Inc.

Role of Genetic Testing in Advanced M1 CRPC & M1 CPRC Post-docetaxel, Neuroendocrine Cancer and End of Life Care Presented by Leonard Gomella, MD and Joshua Lang, MD https://auau.auanet.org/node/34071 Acknowledgements Support provided by independent educational grants from: Amgen Astellas AstraZeneca Bayer HealthCare Pharmaceuticals Inc. Exact Sciences Corporation Merck Pfizer, Inc. Sanofi Genzyme

Optimizing the Treatment of Complicated UTIs CME Available: https://auau.auanet.org/node/33500 ACKNOWLEDGEMENT: This activity is supported by an independent educational grant from Spero Therapeutics.

Early M1 CRPC & Advanced M1 CRPC Presented by Kelly Stratton, MD and Deborah Kaye, MD CME Available: https://auau.auanet.org/node/34065 Acknowledgements Support provided by independent educational grants from: Amgen Astellas AstraZeneca Bayer HealthCare Pharmaceuticals Inc. Exact Sciences Corporation Merck Pfizer, Inc. Sanofi Genzyme

Advances in Immuno-Oncology in Urothelial Carcinoma Podcast (2021) CME Available: https://auau.auanet.org/node/33484 This educational series is supported by independent educational grants from: Astellas AstraZeneca Lantheus Medical Imaging Merck Pfizer, Inc.

BCR and Novel Pet Imaging & M0 CRPC Presented by Stephen Boorjian, MD and Michael Cookson, MD CME Available: https://auau.auanet.org/node/34059 Acknowledgements Support provided by independent educational grants from: Amgen Astellas AstraZeneca Bayer HealthCare Pharmaceuticals Inc. Exact Sciences Corporation Merck Pfizer, Inc. Sanofi Genzyme

This podcast was funded by and developed in collaboration with Boston Scientific

CME Available: https://auau.auanet.org/node/33094 Acknowledgements This educational activity is supported by an independent educational grant from: Urovant

CME Available: https://auau.auanet.org/node/33093 At the conclusion of the activity, participants will be able to: 1. Describe recent developments in the medical management of advanced prostate cancer. 2. Identify the active agents and their mechanism of action in the management of mHSPC, nmCRPC and mCRPC. 3. Discuss clinical investigations in the treatment of advanced prostate cancer. 4. Analyze the risks and benefits of treatment for advanced prostate cancer. 5. Identify the criteria for genetic and genomic testing and utilize the results to improve outcomes among patients with advanced prostate cancer. Acknowledgements This educational activity is supported by independent educational grants from Astellas, AstraZeneca, Merck, Pfizer, Inc.

NMIBC Guidelines by AUAUniversity